Life Sciences Training Course Calendar

Back to details

Training format

Topic

Our Life Sciences calendar for the next 12 months:

Live online Classroom 2025 2026
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Mar Mar
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Regulatory Affairs 4
A Practical Approach to Veterinary Vaccine Development and Registration in the EU Regulatory Affairs 13-14 6-7
A Practical Guide to Producing and Maintaining the PSMF Vigilance 23 3
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 11 12
A Practical Introduction to Good Clinical Practice (GCP) GxP 24 7
A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK Regulatory Affairs 30 21
AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects Clinical Research 30 6
AI in Pharmacovigilance Vigilance 7 19
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Vigilance 10 3
Advanced Pharmacovigilance Vigilance 2-4 6-10
Advanced Project Management in Clinical Research Clinical Research 3
Advanced Regulatory Affairs for Medical Devices Regulatory Affairs 3-4 2-3
Advanced Veterinary Pharmacovigilance Vigilance 17-18 15-16
An Essential Overview of Medical Information Regulatory Affairs 18 4
An Essential Overview of Pharmacovigilance Vigilance 15 8-9
An Essential Overview of the Medical Device Industry Regulatory Affairs 3 7
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 12 22
An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices GxP 10
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 9 20
An Introduction to ISO 11607 - Packaging for Terminally Sterilized Medical Devices GxP 22 17
An Introduction to ISO 13485: 2016 - Quality Management System (QMS) for Medical Devices GxP 3 19
An Introduction to Pharmaceutical Packaging GxP 2-4 30-2
An Introduction to Technology Transfer for Solid Dosage Forms GxP 4 14 6 6
An Introduction to the Design and Development of Medical Devices Medical Technology 23-24 10-11
An Introduction to the Medical Device Regulation Regulatory Affairs 16-18 3-5
An introduction to Risk Management ISO 14971:2019 Regulatory Affairs 11 11
Animal Feed and Feed Additive Registration in China and Thailand Regulatory Affairs 26 23
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Regulatory Affairs 17 10
Balancing Costs and Compliance: The Financial Side of GMP GxP 6 24
Be In the Know With Pharma 4.0: Building The Business Case For Pharma 4.0 Medical Technology 16
Be In the Know With Pharma 4.0: Digital CMC Medical Technology 23
Be In the Know With Pharma 4.0: Digital Technology Transfer Medical Technology 9
Best Practice for Writing Effective SOPs Regulatory Affairs 17 4
Best Practices for Supplier Qualification in Life Science GxP 16-17 13-14
Biological Evaluation of Medical Devices Regulatory Affairs 15-16
Biosimilars Biopharma 30-1
Biotechnology for the Non-Biotechnologist Biopharma 9-11 10-14
Breaking the Code – Achieving Publication Success in Scientific Journals: Dealing with Reviewers' Comments and Resubmission Medical Writing 14 24 23 23
Breaking the Code – Achieving Publication Success in Scientific Journals: Journal Submission and Publication Medical Writing 7 17 16 16
Breaking the Code – Achieving Publication Success in Scientific Journals: Selecting Your Journal Medical Writing 30 10 9 9
Breaking the Code – Achieving Publication Success in Scientific Journals: The Essentials Medical Writing 23 3 2 2
CAPA (Corrective and Preventative Action) Regulatory Affairs 18 5
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 26-27 20-21
Classification of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 25 12
Cleaning Validation - Best Practice in Pharmaceuticals GxP 8-9 2-3
Clinical & Post-Marketing Safety Vigilance 17-18 20-21
Clinical Evaluation of Medical Device Software and Software as a Medical Device Clinical Research 1
Clinical Evaluation of Medical Devices: The Clinical Evaluation Report Clinical Research 21-22 25-26
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 18-19 1-2
Clinical Quality Management Systems Clinical Research 22-23 18-19
Clinical Research Project Management Clinical Research 11-13 22-24
Clinical Trial Monitoring Clinical Research 21-22 8-9
Clinical Trial Regulatory Requirements Clinical Research 8-9 15-16
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 17
Cosmetovigilance Vigilance 19-20 13-14
Cyber Security for Medical Devices Regulatory Affairs 20-21 11-12
Data Innovation for AI-enabled Medical Devices Regulatory Affairs 25 12
Data Integrity Auditor Masterclass GxP 12-13 15-16
Data Integrity and Document Management GxP 14 11
Deep Dive into the IVDR Annex XIII Regulatory Affairs 10 5
Developing and Managing Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 26 13
Development of Combination Products: Critical Interactions GxP 24-25 2-3
Digital CMC: The Key To Realising Pharma 4.0 GxP 7 1
Digital Technology and Personalisation in Patient Support Programmes Clinical Research 2 5
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 2-3 13-14
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 9-10 6-7
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 19 16
Effective Technical Writing & Editing Medical Writing 5 30
Effective Technology Transfer GxP 2-3 6-7
European Post-Marketing Pharmacovigilance Vigilance 14-16 3-7
FDA Approval Process for Medical Devices Regulatory Affairs 2-3
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 7 21
GMP Principles in Vaccine Manufacturing GxP 10-11 10-11
Global Market Access for Medical Device Software Regulatory Affairs 8-9 1-2
Golden Rules of Being a Successful GMP Auditor GxP 2-3 1-2
Good Distribution Practices of Pharmaceuticals and APIs GxP 9-10 17-18
How to Audit Pharmaceutical Suppliers (Material and Service) GxP 26-27 24-25
How to Deal with Difficult Situations in GMP Audits GxP 4 6 5 5
How to Interview During GMP Audits GxP 11 10 12 12
How to Manage Internal GMP Audits GxP 23-24 20-21
How to Pass International Health Authority Inspections GxP 19-20 8-9
How to Perform Bullet-Proof Good Distribution Practices (GDP) and Good Storage Practices (GSP) Audits GxP 14-15 3-4 19-20 19-20
Human Factors and Usability Engineering in the Development of Drug Delivery Products Regulatory Affairs 16-17
ICH Q9(R1) Quality Risk Management (QRM) GxP 17
Innovate: The MedTech Series – A Journey Through Innovation to an AI-Driven Future Medical Technology 15 7
Innovate: The MedTech Series – The 2024 EU AI Act Regulatory Affairs 2
Introduction to Veterinary Pharmacovigilance Vigilance 3-4 5-6
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Regulatory Affairs 16-17 4-5
Introduction to the New Performance Evaluation Requirements Mandated Under the IVDR (2017/746) Regulatory Affairs 9 4
Literature Searching in Drug Safety Vigilance 11-12 12-13
Making Financial Sense of GMP: Change Management GxP 11 14 13 13
Making Financial Sense of GMP: Pharmaceutical Quality System (PQS) GxP 13 3
Making Financial Sense of GMP: Quality Risk Management (QRM) GxP 27 7 6 6
Making Financial Sense of GMP: Validation Master Plan (VMP) GxP 20 10
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 23-24 16-17
Market Authorisation of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 23-24 10-11
Masterclass: Market Authorisation of AI-enabled Medical Devices Regulatory Affairs 27 14
Mastering Ethical and Effective Scientific Publishing: Applying Good Publication Practice (GPP) Medical Writing 25 14 20
Mastering Grant Writing: Essential Skills for Crafting Winning Proposals Medical Writing 10-11 9-10 13-14
Medical Device Regulation in the Eurasian Union, Russia and the CIS Regulatory Affairs 23-24 9-10
Medical Device Regulations in Asia-Pacific Markets Regulatory Affairs 1-2 4-5 3-4 3-4
Medical Device Regulations in the Middle East and North Africa Regulatory Affairs 16-17 19-20
Medical Device Single Audit Programme (MDSAP) GxP 10-11 26-27
Medical Device Studies: Clinical Evidence Clinical Research 15-16
Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Clinical Research 15-16
Medical Writing Excellence: Crafting Compelling Scientific Documents Medical Writing 10-11
Medical Writing for Medical Devices Medical Writing 1-2 20-21
Medical Writing with Alex Evans: Medical Editing for Peer-Reviewed Journals Medical Writing 8
Medical Writing with Alex Evans: Medical Writing for Consumers Medical Writing 1
Medical Writing with Alex Evans: Medical Writing with Artificial Intelligence (AI) Medical Writing 15
Metered Dose Inhaler (MDI) Technology Medical Technology 19-20 8-9
Metrics and Earned Value in Clinical Research Projects Clinical Research 22 24
Microbiomics in Clinical Trials Clinical Research 4 14
Molecular Biology for the Non-molecular Biologist Biopharma 3-4 9-10
Molecule to Medicine: An Introduction to Signal Detection Vigilance 16 15 16
Molecule to Medicine: An Introduction to Upstream and Downstream Manufacturing in the Biopharmaceutical Industry GxP 12 5
Molecule to Medicine: An Introduction to the ‘Soft Side’ of Technology Transfers GxP 16 3
Navigating China’s API Regulations: An Essential Guide to DMF Registration GxP 23 23
Navigating ICH GCP E6 (R3): What You Need to Know Clinical Research 20 12 15
Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests Regulatory Affairs 26 6
New EU GMP Annex 1: Compliant Aseptic Operations GxP 1-3 25-27
Non-Conformance and Corrective Action for Medical Device Manufacturers Regulatory Affairs 18 11
Pharmaceutical Development of ATMPs GxP 17-18 13-14
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 22-23 4-5
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 11-13 8-10
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 25-26 26-27
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 19-20 2-3
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 23-24 21-22
Pharmacovigilance Aspects of Licensing Agreements Vigilance 1 1-2
Pharmacovigilance QMS & Inspection Preparation Vigilance 19-20 25-26
Post-Market Surveillance - Practical Application for Medical Devices and IVDs Regulatory Affairs 5 9
Post-Market Surveillance and Vigilance of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Vigilance 10-11 3-4
Practical Implementation of GCP in Veterinary Field Studies GxP 14-15 25-26
Practical Implementation of a Human Factors Study Regulatory Affairs 1-2 18-19
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 12-13 16-17
Pre-Filled Syringes: End-to-End Processing Medical Technology 21-22 5-6
Process Validation for Medical Devices GxP 5-6 22-23
Process Validation with Qualification GxP 20-21 22-23
Protein Engineering for Pharmaceutical Biotechnology Biopharma 10-11 21-22
Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in Pharma Clinical Research 16 19
Registration of Veterinary Pharmaceuticals in China Regulatory Affairs 26 23
Regulatory Affairs for Support Staff Regulatory Affairs 22-23
Regulatory Compliance and Safety Standards for Aesthetic Devices Regulatory Affairs 12 5
Regulatory Strategies for Orphan Drugs Regulatory Affairs 23 7
Responsible Conduct of Research (RCR): Good Clinical Practice (GCP) GxP 12 8
Responsible Conduct of Research (RCR): Good Documentation Practice (GDocP) GxP 19 15
Responsible Conduct of Research (RCR): Good Publication Practice (GPP) GxP 9 29 3 3
Responsible Conduct of Research (RCR): Good Writing Practice (GWP) GxP 2 22
Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP) Vigilance 24
Risk Management for Clinical Research Clinical Research 6 7
Signal Detection and Regulatory Expectations Vigilance 7-8 18-21
Signal Detection: A Comprehensive Introduction Vigilance 22 15
Smart Packaging and Electronic Patient Information GxP 3 3-4
Software Automation in Research and Development (R&D) Clinical Trials Clinical Research 4 1
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 21-22 10-11
Sterilization of Medical Devices GxP 5-6 16-17
Successful Medical Writing – from Protocol to CTD Medical Writing 5-6 25-26
Sustainable Design and Manufacture for Medical Devices Medical Technology 3 27
The Animal Health Summer School: Working Through Veterinary Drug Development in the EU and USA Regulatory Affairs 16-19
The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Biopharma 9-10 12-13 11-12 11-12
The Common Technical Document GxP 7-8 24-25
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 1 28
The FDA Drug Approval Process Regulatory Affairs 11-12 7-8
The Future of Manufacturing: 3D Printing for Medical Devices Medical Technology 10 10
The Medical Device School - From Concept to CE Marking Regulatory Affairs 9-13
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Regulatory Affairs 12-13 13-14
The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR and IVDR Regulatory Affairs 22 22
Thinking Outside of the GMP Box GxP 17-18
UK Conformity Assessed (UKCA) Marking for Medical Devices Regulatory Affairs 26 21
US FDA - Understanding Key Factors When Working with the FDA Biopharma 11 26
Understanding Active Pharmaceutical Ingredients (APIs) GxP 16-17 19-20
Understanding Computer System Validation (CSV) GxP 9-10 24-25
Understanding Pharmacovigilance Regulations in APAC Vigilance 16-17 9-10
Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers Regulatory Affairs 8 20
Utilising Patient Adherence Data and Digital Tools to Improve Patient Outcomes Clinical Research 18 15
Variations to Marketing Authorisations Regulatory Affairs 9-10 15-16
Veterinary Pharmaceutical Submissions in the EU Regulatory Affairs 19-20 25-26